As of 2025-10-16, the Relative Valuation of Ionis Pharmaceuticals Inc (IONS) is (23.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 72.39 USD, the upside of Ionis Pharmaceuticals Inc based on Relative Valuation is -132.4%.
The range of the Relative Valuation is (16.63) - (24.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 14.5x | 13.9x |
| Forward P/E multiples | 9.9x - 14.4x | 14.0x |
| Fair Price | (16.63) - (24.30) | (23.47) |
| Upside | -123.0% - -133.6% | -132.4% |
| Date | P/E |
| 2025-10-15 | -43.02 |
| 2025-10-14 | -42.41 |
| 2025-10-13 | -41.95 |
| 2025-10-10 | -41.58 |
| 2025-10-09 | -41.76 |
| 2025-10-08 | -41.57 |
| 2025-10-07 | -40.97 |
| 2025-10-06 | -41.02 |
| 2025-10-03 | -41.09 |
| 2025-10-02 | -40.65 |
| 2025-10-01 | -39.10 |
| 2025-09-30 | -38.88 |
| 2025-09-29 | -38.12 |
| 2025-09-26 | -38.09 |
| 2025-09-25 | -37.42 |
| 2025-09-24 | -38.00 |
| 2025-09-23 | -37.18 |
| 2025-09-22 | -36.46 |
| 2025-09-19 | -36.26 |
| 2025-09-18 | -36.69 |
| 2025-09-17 | -36.35 |
| 2025-09-16 | -36.44 |
| 2025-09-15 | -36.31 |
| 2025-09-12 | -37.53 |
| 2025-09-11 | -38.06 |
| 2025-09-10 | -38.03 |
| 2025-09-09 | -38.27 |
| 2025-09-08 | -36.25 |
| 2025-09-05 | -36.39 |
| 2025-09-04 | -35.27 |
| 2025-09-03 | -35.95 |
| 2025-09-02 | -34.16 |
| 2025-08-29 | -25.34 |
| 2025-08-28 | -25.33 |
| 2025-08-27 | -25.40 |
| 2025-08-26 | -25.06 |
| 2025-08-25 | -24.85 |
| 2025-08-22 | -25.37 |
| 2025-08-21 | -25.69 |
| 2025-08-20 | -25.44 |
| 2025-08-19 | -25.24 |
| 2025-08-18 | -25.81 |
| 2025-08-15 | -26.02 |
| 2025-08-14 | -25.46 |
| 2025-08-13 | -25.61 |
| 2025-08-12 | -24.61 |
| 2025-08-11 | -24.27 |
| 2025-08-08 | -24.74 |
| 2025-08-07 | -24.39 |
| 2025-08-06 | -24.18 |